Evaluation of serum chromogranin A as a useful tumor marker for diagnosis of hepatocellular carcinoma
• 2011
Publication Information
Authors
Ahmed M Awadallah, Hesham Ali Issa, Mohamed S Soliman
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: In Egypt, HCC was reported to account for about 4.7% of chronic liver
disease patients. Approximately 80% of HCCs are associated with cirrhosis, which is
regarded as the most important precancerous etiological factor. Chromogranin A is a cellular
marker for neuroendocrine tumors. High serum levels of CgA have also been demonstrated
in patients with other malignancies including colon, lung, breast and prostate cancer.
Objective: To evaluate serum CgA as a marker for HCC. Patients and Methods: Eighty .
disease patients. Approximately 80% of HCCs are associated with cirrhosis, which is
regarded as the most important precancerous etiological factor. Chromogranin A is a cellular
marker for neuroendocrine tumors. High serum levels of CgA have also been demonstrated
in patients with other malignancies including colon, lung, breast and prostate cancer.
Objective: To evaluate serum CgA as a marker for HCC. Patients and Methods: Eighty .
Staff Members - Benha University